Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Foster City, California
- Most recent report
- 8-K, filed Oct 1, 2026
- Incorporated
- Delaware
- Filings on record
- 261 filings
- On EDGAR
- CIK 1400118
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 13
News 8 of 53
Prospectuses and Registrations 8 of 20
- 424B5 Prospectus supplement for an offering Oct 1, 2026
- 424B3 Prospectus supplement for an offering Sep 30, 2026
- 424B5 Prospectus supplement for an offering Apr 28, 2026
- S-8 Registration statement for an employee plan Mar 11, 2026
- S-8 Registration statement for an employee plan Mar 11, 2026
- 424B5 Prospectus supplement for an offering Aug 14, 2025
- S-8 Registration statement for an employee plan Mar 12, 2025
- S-8 Registration statement for an employee plan Mar 12, 2025
Proxies 4
Ownership 8 of 129
- SCHEDULE 13G Large holder reported a passive stake Oct 7, 2026
- 4 Insider reported a trade Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Aug 12, 2026
- 144 Notice of a proposed sale of restricted stock Aug 11, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 30, 2026
- 4 Insider reported a trade Jul 22, 2026
Other 8 of 42
- ARS Annual report sent to shareholders Apr 21, 2026
- UPLOAD Comment letter from SEC staff May 7, 2025
- CORRESP Reply to SEC staff May 5, 2025
- ARS Annual report sent to shareholders Apr 30, 2025
- UPLOAD Comment letter from SEC staff Apr 22, 2025
- EFFECT Notice that a registration became effective Aug 26, 2024
- CORRESP Reply to SEC staff Aug 22, 2024
- UPLOAD Comment letter from SEC staff Aug 19, 2024
Everything here comes from Sagimet Biosciences Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.